Award: Department of Health and Human ServicesNAICS n/aSAM# HHSO100201700016CPosted 2026-07-13 · Response deadline 2027-09-29 · Set-aside: None
Recipient: REGENERON PHARMACEUTICALS INC | $693056926.67
View official SAM.gov notice →
← All opportunities